150 related articles for article (PubMed ID: 28213274)
1. Differentially cleaving peptides as a strategy for controlled drug release in human retinal pigment epithelial cells.
Bhattacharya M; Sarkhel S; Peltoniemi J; Broadbridge R; Tuomainen M; Auriola S; Urtti A
J Control Release; 2017 Apr; 251():37-48. PubMed ID: 28213274
[TBL] [Abstract][Full Text] [Related]
2. Nucleic acid delivery to differentiated retinal pigment epithelial cells using cell-penetrating peptide as a carrier.
Subia B; Reinisalo M; Dey N; Tavakoli S; Subrizi A; Ganguli M; Ruponen M
Eur J Pharm Biopharm; 2019 Jul; 140():91-99. PubMed ID: 31085311
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan-modified core-shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection.
Gan L; Wang J; Zhao Y; Chen D; Zhu C; Liu J; Gan Y
Biomaterials; 2013 Aug; 34(24):5978-87. PubMed ID: 23680367
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.
Yang CH; Huang TF; Liu KR; Chen MS; Hung PT
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):843-54. PubMed ID: 8603869
[TBL] [Abstract][Full Text] [Related]
5. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.
Bourges JL; Gautier SE; Delie F; Bejjani RA; Jeanny JC; Gurny R; BenEzra D; Behar-Cohen FF
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3562-9. PubMed ID: 12882808
[TBL] [Abstract][Full Text] [Related]
6. Controlled production of active cathepsin D in retinal pigment epithelial cells following adenovirus-mediated gene delivery.
Lai CM; Robertson T; Papadimitriou J; Shen WY; Daw N; Constable IJ; Rakoczy PE
Mol Ther; 2000 Nov; 2(5):476-84. PubMed ID: 11082321
[TBL] [Abstract][Full Text] [Related]
7. Release of functional dexamethasone by intracellular enzymes: A modular peptide-based strategy for ocular drug delivery.
Bhattacharya M; Sadeghi A; Sarkhel S; Hagström M; Bahrpeyma S; Toropainen E; Auriola S; Urtti A
J Control Release; 2020 Nov; 327():584-594. PubMed ID: 32911015
[TBL] [Abstract][Full Text] [Related]
8. Effect of eye pigmentation on transscleral drug delivery.
Cheruvu NP; Amrite AC; Kompella UB
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):333-41. PubMed ID: 18172110
[TBL] [Abstract][Full Text] [Related]
9. Uptake of 3H-cAMP by retinal pigment epithelium isolated from bluegill sunfish (Lepomis macrochirus).
Keith TA; Radhakrishnan V; Moredock S; García DM
BMC Neurosci; 2006 Dec; 7():82. PubMed ID: 17196104
[TBL] [Abstract][Full Text] [Related]
10. Influence of pigment content, intracellular calcium and cyclic AMP on the ability of human retinal pigment epithelial cells to contract collagen gels.
Smith-Thomas LC; Richardson PS; Rennie IG; Palmer I; Boulton M; Sheridan C; MacNeil S
Curr Eye Res; 2000 Jul; 21(1):518-29. PubMed ID: 11035531
[TBL] [Abstract][Full Text] [Related]
11. Role of retinal pigment epithelium permeability in drug transfer between posterior eye segment and systemic blood circulation.
Ramsay E; Hagström M; Vellonen KS; Boman S; Toropainen E; Del Amo EM; Kidron H; Urtti A; Ruponen M
Eur J Pharm Biopharm; 2019 Oct; 143():18-23. PubMed ID: 31419586
[TBL] [Abstract][Full Text] [Related]
12. Melanosome motility in fish retinal pigment epithelial cells.
King-Smith C
Methods Mol Biol; 2009; 586():275-82. PubMed ID: 19768436
[TBL] [Abstract][Full Text] [Related]
13. Effect of choroidal perfusion on ocular tissue distribution after intravitreal or suprachoroidal injection in an arterially perfused ex vivo pig eye model.
Abarca EM; Salmon JH; Gilger BC
J Ocul Pharmacol Ther; 2013 Oct; 29(8):715-22. PubMed ID: 23822159
[TBL] [Abstract][Full Text] [Related]
14. The enzymatic cleavage of rhodopsin by the retinal pigment epithelium. I. Enzyme preparation, properties and kinetics: characterization of the glycopeptide product.
Hara S; Plantner JJ; Kean EL
Exp Eye Res; 1983 Jun; 36(6):799-816. PubMed ID: 6222914
[TBL] [Abstract][Full Text] [Related]
15. Intraocular implantation of DNA-transfected retinal pigment epithelium cells: a new approach for analyzing molecular functions in the newt retinal regeneration.
Chiba C; Nakamura K; Unno S; Saito T
Neurosci Lett; 2004 Sep; 368(2):171-5. PubMed ID: 15351443
[TBL] [Abstract][Full Text] [Related]
16. Regional comparisons of cathepsin D activity in bovine retinal pigment epithelium.
Burke JM; Twining SS
Invest Ophthalmol Vis Sci; 1988 Dec; 29(12):1789-93. PubMed ID: 3192367
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles for gene delivery to retinal pigment epithelial cells.
Bejjani RA; BenEzra D; Cohen H; Rieger J; Andrieu C; Jeanny JC; Gollomb G; Behar-Cohen FF
Mol Vis; 2005 Feb; 11():124-32. PubMed ID: 15735602
[TBL] [Abstract][Full Text] [Related]
18. Differential permeance of retina and retinal pigment epithelium to water: implications for retinal adhesion.
Kirchhof B; Ryan SJ
Int Ophthalmol; 1993 Feb; 17(1):19-22. PubMed ID: 8314656
[TBL] [Abstract][Full Text] [Related]
19. Screening of chemical linkers for development of pullulan bioconjugates for intravitreal ocular applications.
Balasso A; Subrizi A; Salmaso S; Mastrotto F; Garofalo M; Tang M; Chen M; Xu H; Urtti A; Caliceti P
Eur J Pharm Sci; 2021 Jun; 161():105785. PubMed ID: 33667663
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cell-induced vitreous contraction by synthetic peptide derived from the collagen receptor binding sequence.
Yang CH; Huang TF; Liu KR; Chen MS; Hung PT
J Ocul Pharmacol Ther; 1996; 12(3):353-61. PubMed ID: 8875342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
